EML2 activators, as described in the context of this research, can be comprehended as chemical entities indirectly influencing EML2 by targeting associated microtubule dynamics. Microtubules, being one of the primary cytoskeletal filaments, regulate various cellular processes, and their dynamic instability is vital for functions like cell division and intracellular transport. EML2, by interacting with microtubules, plays a significant role in these processes. Therefore, compounds affecting microtubule dynamics can inevitably modulate EML2's function, even if not directly targeting the protein.
For instance, agents such as epothilone B stabilize microtubules, enhancing their polymerization. A stabilized microtubule network can influence the manner and extent to which EML2 interacts with these structures, modulating its functional role. Conversely, compounds like vinblastine and nocodazole disrupt microtubule stability. Such destabilization can lead to an altered microtubule landscape, subsequently changing how EML2 exercises its role in the cell. Additionally, some agents, like colchicine, work by directly binding tubulin subunits, their polymerization into microtubules. The subsequent change in microtubule-tubulin equilibrium can impact proteins like EML2 that rely on microtubules for their functionality. The cell's microtubule network, being dynamic, is continuously undergoing polymerization and depolymerization, with numerous proteins like EML2 playing roles in this delicate balance. Chemical agents that tip this balance, whether towards stabilization or destabilization, indirectly affect EML2 and similar proteins' activities. Thus, understanding these EML2 activators is not just about recognizing the chemicals themselves, but also comprehending the broader microtubule dynamics in the cell and how shifts in this dynamic can cascade to influence various interacting proteins, including EML2. This intricate interplay between chemicals, microtubules, and proteins such as EML2 underscores the complexity of cellular processes and the of these agents to serve as indirect modulators of EML2's function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Destabilizes microtubules by binding β-tubulin. Altered dynamics can influence EML2's functional role. | ||||||
Epothilone B, Synthetic | 152044-54-7 | sc-203944 | 2 mg | $176.00 | ||
Stabilizes microtubules similarly to paclitaxel. Stabilized microtubules can indirectly modulate EML2's interactions. | ||||||
MCC950 sodium salt | 256373-96-3 | sc-505904 sc-505904A sc-505904B sc-505904C | 5 mg 10 mg 50 mg 100 mg | $114.00 $198.00 $888.00 $1569.00 | 3 | |
Microtubule stabilizing agent. Enhances microtubule assembly, affecting EML2's interaction dynamics with microtubules. | ||||||
Laulimalide | 115268-43-4 | sc-507261 | 100 µg | $200.00 | ||
Stabilizes microtubules by a different binding site than paclitaxel. Stability can modify EML2's activity in the cell. | ||||||
Estramustine | 2998-57-4 | sc-353281 sc-353281A | 100 mg 1 g | $265.00 $743.00 | ||
Binds tubulin, inhibiting microtubule polymerization. Indirectly affects EML2's interaction with microtubules. | ||||||
Albendazole | 54965-21-8 | sc-210771 | 100 mg | $213.00 | 1 | |
Microtubule depolymerizing agent. Disrupted microtubule dynamics can lead to changes in EML2's activity. | ||||||